EICHORPublic-registry site landscape for NCT01702155, “Phase I/II Study of DFP-10917 in Patients With Acute Leukemia”, a Acute Myeloid Leukemia study sponsored by Delta-Fly Pharma, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT01702155 (registry record) |
| Study title | Phase I/II Study of DFP-10917 in Patients With Acute Leukemia |
| Official title | A Phase I/II Study of DFP 10917 Given by Continuous Infusion in Patients With Relapsed or Refractory Acute Leukemia |
| Sponsor | Delta-Fly Pharma, Inc. |
| Condition(s) | Acute Myeloid Leukemia; Acute Lymphocytic Leukemia |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 1 |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT01702155.
Eichor generates a preliminary site-risk snapshot for NCT01702155 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Acute Myeloid Leukemia trials
← Eichor home · All tracked trials · Acute Myeloid Leukemia studies · Weekly briefs
